| Literature DB >> 34999594 |
Celina I von Eiff1,2, Verena G Skuk1,2,3,4,5,6, Romi Zäske1,2,3,4,5,6, Christine Nussbaum1,2, Sascha Frühholz4,5, Ute Feuer6, Orlando Guntinas-Lichius3, Stefan R Schweinberger1,2.
Abstract
OBJECTIVES: Research on cochlear implants (CIs) has focused on speech comprehension, with little research on perception of vocal emotions. We compared emotion perception in CI users and normal-hearing (NH) individuals, using parameter-specific voice morphing.Entities:
Mesh:
Year: 2022 PMID: 34999594 PMCID: PMC9197138 DOI: 10.1097/AUD.0000000000001181
Source DB: PubMed Journal: Ear Hear ISSN: 0196-0202 Impact factor: 3.562
Demographic characteristics of all CI users
| CI user | Performance rank | Sex | Age | Civil status | Pre-/post-deaf | Age at deafness | Age at first CI (yr) | Mode of hearing | Left CI | Right CI | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wear time (hr) | Manufacturer | Processor | Wear time (hr) | Manufacturer | Processor | |||||||||
| 11 | 4 (HP) | Female | 61 | Widowed | Post | 40 | 60 | CI-left | 12–16 | Cochlear | CP910 | / | / | / |
| 12 | 21 (LP) | Female | 47 | Single | Pre | 0 | 45 | CI-bi | > 16 | Advanced Bionics | Naida Q90 | > 16 | Advanced Bionics | Naida Q90 |
| 13 | 20 (LP) | Female | 76 | Widowed | Post | 19 | 70 | CI-bi | 12–16 | MED-EL | OPUS2 | 12–16 | MED-EL | Sonnet |
| 14 | 12 (HP) | Male | 68 | Married | Post | 40 | 67 | CI-right | / | / | / | > 16 | Cochlear | CP910 |
| 15 | 19 (LP) | Female | 56 | Married | Pre | 0 | 54 | CI-bi | 12–16 | Cochlear | CP910 | 12–16 | Cochlear | CP910 |
| 16 | 7 (HP) | Female | 50 | Divorced | Post | 3 | 46 | CI-bi | > 16 | MED-EL | OPUS2 | > 16 | MED-EL | Sonnet |
| 17 | 17 (LP) | Male | 68 | Married | Post | 66 | 68 | CI-bi | 12–16 | Cochlear | Kanso | 12–16 | Cochlear | Kanso |
| 18 | 11 (HP) | Male | 67 | Married | Post | 40 | 66 | CI-left | 12–16 | Cochlear | CP910 | / | / | / |
| 19 | 6 (HP) | Female | 57 | Divorced | Post | 12 | 55 | CI-bi | 12–16 | Advanced Bionics | Naida Q90 | 12–16 | Advanced Bionics | Naida Q90 |
| 20 | 10 (HP) | Female | 81 | Widowed | Post | 65 | 81 | CI-right | / | / | / | > 16 | MED-EL | Sonnet |
| 21 | 1 (HP) | Male | 64 | Married | Post | 59 | 63 | CI-right | / | / | / | 12–16 | MED-EL | Sonnet |
| 22 | 24 (LP) | Male | 41 | Single | Post | 3 | 41 | CI-right | / | / | / | 8–12 | Advanced Bionics | Naida Q90 |
| 23 | 18 (LP) | Female | 69 | Married | Post | 40 | 69 | CI-right | / | / | / | 8–12 | Cochlear | Kanso |
| 24 | 15 (LP) | Male | 67 | Single | Post | 50 | 53 | CI-bi | 12–16 | MED-EL | OPUS2 | 0–4 | MED-EL | Sonnet |
| 25 | 9 (HP) | Female | 76 | Widowed | Post | 62 | 74 | CI-bi | 12–16 | MED-EL | Sonnet | 12–16 | MED-EL | Sonnet |
| 26 | 23 (LP) | Female | 51 | Divorced | Post | 25 | 50 | CI-bi | 12–16 | Cochlear | CP910 | 12–16 | Cochlear | CP910 |
| 27 | 16 (LP) | Female | 80 | Married | Post | 40 | 79 | CI-right | / | / | / | 8–12 | Cochlear | CP910 |
| 28 | 14 (LP) | Male | 27 | Single | Pre | 0 | 25 | CI-bi | 12–16 | MED-EL | Sonnet | 12–16 | MED-EL | Sonnet |
| 29 | 25 (LP) | Female | 36 | Single | Pre | 0 | 29 | CI-bi | 8–12 | Cochlear | Kanso | 8–12 | Cochlear | CP910 |
| 30 | 13 (HP) | Male | 76 | Married | Post | 44 | 75 | CI-right | / | / | / | 12–16 | Cochlear | CP910 |
| 31 | 2 (HP) | Female | 72 | Married | Post | 50 | 72 | CI-left | 12–16 | Cochlear | Kanso | / | / | / |
| 32 | 22 (LP) | Male | 83 | Married | Post | 20 | 83 | CI-left | 8–12 | Cochlear | CP910 | / | / | / |
| 33 | 8 (HP) | Male | 20 | Widowed | Pre | 0 | 2 | CI-bi | 12–16 | Advanced Bionics | Harmony | 12–16 | Advanced Bionics | Harmony |
| 34 | 3 (HP) | Male | 77 | Single | Post | 74 | 76 | CI-left | 4–8 | MED-EL | Sonnet | / | / | / |
| 35 | 5 (HP) | Female | 54 | Married | Post | 3 | 53 | CI-left | 12–16 | Advanced Bionics | Naida Q90 | / | / | / |
|
| 61.0 | 30.20 | 58.24 | |||||||||||
|
| 17.0 | 25.06 | 19.37 | |||||||||||
| Minimum | 20 | 0 | 2 | |||||||||||
| Maximum | 83 | 74 | 83 | |||||||||||
| N | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
CI Manufacturers: Advanced Bionics GmbH, Max-Eyth-Str. 20, 70736 Fellbach-Oeffingen, Germany; Cochlear Headquarters, 1 University Avenue, Macquarie University, NSW, 2109, Australia; MED-EL Elektromedizinische Geräte Gesellschaft m.b.H., Fürstenweg 77a, 6020 Innsbruck, Austria.
CI, cochlear implant; CI-bi, bilateral implanted CI user; CI-left, unilateral implanted CI user who was fitted with the CI on the left ear; CI-right, unilateral implanted CI user who was fitted with the CI on the right ear; HP, high-performing subgroup of CI users (n = 13); LP, low-performing subgroup of CI users (n = 12); post = postlingually deafened; pre = prelingually deafened.
Acoustic characteristics of stimuli used as continuum endpoints
| Female speakers | Male speakers | Paired | ||||
|---|---|---|---|---|---|---|
| Anger | Fear | Anger | Fear |
| ||
| F0 mean (in Hz) | 366 | 288 | 264 | 205 | 3.69 | 0.002 |
| F0 | 67.1 | 19.0 | 45.6 | 26.8 | 6.50 | 0.001 |
| F0 intonation (in Hz) | 259 | 79 | 171 | 95 | 6.99 | 0.001 |
| F0 glide (in Hz) | –60 | 3 | –41 | 12 | –3.08 | 0.007 |
| Formant dispersion (in Hz) | 910 | 1043 | 819 | 1074 | –5.61 | 0.001 |
| Alpha ratio | 1.0 | 2.3 | 1.1 | 2.28 | –11.16 | 0.001 |
| HNR | 12.8 | 21.3 | 7.3 | 19 | –11.44 | 0.001 |
| Duration (in ms) | 885 | 760 | 731 | 854 | 0.02 | 0.988 |
All acoustical parameters were adapted from McAleer et al. (2014) and extracted using Praat software (Boersma 2018). For F0 extraction, pitch ranges were set to 170–600 Hz for female and 100–370 Hz for male stimuli. F0 intonation = F0max–F0min; F0 glide = F0End–F0Start; Formant dispersion = ratio between consecutive formant means (from F1 to F4, maximum formant frequency set to 5 kHz, window length 0.025 s); alpha ratio (a measure of the spectral slope) = ratio of mean energy within low (0–1 kHz) and high frequencies (1–5 kHz), computed from the long-term average spectrum; HNR was extracted with the cross-correlation method (mean value; time step = 0.01 s; min pitch = 75 Hz; silence threshold = 0.1, periods per window = 1.0).
Including both male and female speakers.
HNR, harmonics-to-noise ratio.
Results of the 4 × 6 × 2 × 2 ANOVA on the proportion of “angry”-responses with the factors MType, ML, SpSex, and LGroup
| Main effects and interactions |
|
|
| η | ε |
|---|---|---|---|---|---|
| ML | 185.743 | 5, 240 | < 0.001 | 0.795 | 0.478 |
| SpSex | 11.686 | 1, 48 | 0.001 | 0.196 | |
| LGroup × ML | 24.909 | 5, 240 | < 0.001 | 0.342 | 0.478 |
| MType × ML | 54.647 | 15, 720 | < 0.001 | 0.532 | 0.703 |
| LGroup × MType × ML | 8.432 | 15, 720 | < 0.001 | 0.149 | 0.703 |
| LGroup × ML × SpSex | 6.208 | 5, 240 | < 0.001 | 0.115 | 0.898 |
| MType × ML × SpSex | 2.802 | 15, 720 | < 0.001 | 0.055 |
ANOVA, analysis of variance; df, degrees of freedom; LGroup, listener group; ML, morph level; MType, morph type; SpSex, speaker sex.
Fig. 1.The proportion of “angry”-responses for different morph levels and morph types used in the experiment, separately for normal-hearing individuals and CI users. Note that steeper slopes represent better performance. Error bars represent SEM. Best-fitting cumulative Gaussian functions are also shown. CI, cochlear implant; SEM, standard error of the mean.
Two-way interactions of the 4 × 6 × 2 ANOVA on the proportion of “angry”-responses with the factors MType, ML, and PerfGroup, including both the high-performing and the low-performing CI users
| Main effects and interactions |
|
|
| η | ε |
|---|---|---|---|---|---|
| MType × ML | 10.823 | 15, 345 | < 0.001 | 0.320 | 0.738 |
| PerfGroup × ML | 15.066 | 5, 115 | < 0.001 | 0.396 | 0.698 |
ANOVA, analysis of variance; CI, cochlear implant; df, degrees of freedom; ML, morph level; MType, morph type; PerfGroup, performance group.
Fig. 2.The proportion of “angry”-responses for different morph levels and morph types used in the experiment, separately for the normal-hearing individuals, the high-performing CI users (n = 13), and the low-performing CI users (n = 12). Note that steeper slopes represent better performance. Error bars represent SEM. Best-fitting cumulative Gaussian functions are also shown. CI, cochlear implant; SEM, standard error of the mean.
Results of the explorative 4 × 6 × 2 × 2 ANOVA on the proportion of “angry”-responses with the factors MType, ML, SpSex, and PerfGroup, including the high-performing CI users and the normal-hearing individuals
| Main effects and interactions |
|
|
| η | ε |
|---|---|---|---|---|---|
| ML | 284.578 | 5, 180 | < 0.001 | 0.888 | 0.637 |
| SpSex | 6.594 | 1, 36 | 0.015 | 0.155 | |
| PerfGroup × ML | 7.298 | 5, 180 | < 0.001 | 0.169 | 0.637 |
| MType × ML | 69.354 | 15, 540 | < 0.001 | 0.658 | 0.759 |
| ML × SpSex | 2.360 | 5, 180 | 0.042 | 0.062 | |
| MType × SpSex | 2.705 | 3, 108 | 0.049 | 0.070 | |
| PerfGroup × MType x ML | 2.840 | 15, 540 | 0.001 | 0.073 | 0.759 |
| PerfGroup × ML × SpSex | 3.651 | 5, 180 | 0.004 | 0.092 | |
| MType × ML × SpSex | 2.976 | 15, 540 | 0.001 | 0.076 | 0.796 |
ANOVA, analysis of variance; CI, cochlear implant; df, degrees of freedom; ML, morph level; MType, morph type; PerfGroup, performance group; SpSex, speaker sex.
Results of the 6 x 2 ANOVAs for the morph types F0 and Full on the proportion of “angry”-responses with the factors ML and PerfGroup, including the high-performing CI users and the normal-hearing individuals
| Main effects and interactions |
|
|
| η | ε |
|---|---|---|---|---|---|
| Full | |||||
| ML | 405.728 | 5, 180 | < 0.001 | 0.919 | 0.646 |
| PerfGroup × ML | 6.684 | 5, 180 | < 0.001 | 0.157 | 0.646 |
| F0 | |||||
| ML | 80.518 | 5, 180 | < 0.001 | 0.691 | 0.643 |
| PerfGroup × ML | 8.037 | 5, 180 | < 0.001 | 0.183 | 0.643 |
ANOVA, analysis of variance; CI, cochlear implant; df, degrees of freedom; ML, morph level; PerfGroup, performance group.